Request A Quote
Contact us to discuss how we can help you achieve your research goals
Featured Publications

Therapy-induced APOBEC3A Drives Evolution of Persistent Cancer Cells

Introduction:

Published on August 23, 2023, in the prestigious journal Nature, a study led by Dr Kazuo Isozaki, alongside teams from renowned oncology research centers, explored the intriguing evolution of resistance mutations in non-small cell lung cancers (NSCLCs) treated with tyrosine kinase inhibitors (TKIs). The research in this paper focused on the following key questions:

  • How do non-small cell lung cancers (NSCLCs) develop resistance to tyrosine kinase inhibitors (TKIs)?
  • What role does APOBEC3A-induced mutagenesis play in the evolution of drug-resistant cancer cells?
  • Are there specific mutational signatures associated with APOBEC activity in TKI-treated tumors?
  • Can inhibiting APOBEC3A expression or activity prevent or delay the emergence of drug resistance in NSCLC?

Download Now